Dr. Idos on Remaining Questions With Multiplex Panel Testing

Name: Dr. Idos on Remaining Questions With Multiplex Panel Testing
Uploaded: 2016-09-28T01:09:14.000Z
Description: Gregory E. Idos, MD, assistant professor of Clinical Medicine, Department of Surgery, Division of Colorectal Surgery, Keck School of Medicine of University of Southern California, sheds light on the remaining questions with multiplex panel testing as well as the cost effectiveness of it.

September 27, 2016

Gregory E. Idos, MD

Video

Conference|ASCO Annual Meeting

Gregory E. Idos, MD, assistant professor of Clinical Medicine, Department of Surgery, Division of Colorectal Surgery, Keck School of Medicine of University of Southern California, sheds light on the remaining questions with multiplex panel testing as well as the cost effectiveness of it.

Gregory E. Idos, MD, assistant professor of Clinical Medicine, Department of Surgery, Division of Colorectal Surgery, Keck School of Medicine of University of Southern California, sheds light on the cost effectiveness and other questions surrounding multiplex panel testing.

Currently, researchers are exploring the overall utility of how multiplex panel tests could potentially affect surgical management and chemotherapy prevention, Idos explains.

Regarding cost, using the gene-by-gene approach has been found to be more expensive than multiplex panel testing, he adds. Over the last few years, it has also been found that the cost of sequencing has gone down.